We are live on ! Find out more
NSPR icon

InspireMD

20 hedge funds and large institutions have $4.72M invested in InspireMD in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

638% more capital invested

Capital invested by funds: $640K → $4.72M (+$4.08M)

550% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 2

122% more funds holding

Funds holding: 920 (+11)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0.06% more ownership

Funds ownership: 0.33%0.4% (+0.06%)

Holders
20
Holders Change
+11
Holders Change %
+122.22%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
3
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

NSPR Hedge Fund Activity: Q1 2021 in Review

20 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q1 2021, worth a combined $4.72M — up 638% from $640K a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new NSPR positions and 2 closed out — a net gain of 11 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.5M. The largest seller was Sabby Management, exiting entirely with an estimated $60K sold.

  • 20 institutional investors held InspireMD (NSPR) as of Q1 2021, up from 9 in Q4 2020.
  • Funds reported $4.72M of InspireMD stock for Q1 2021, up 638% quarter-over-quarter.
  • 13 funds opened new InspireMD positions in Q1 2021 and 2 closed out, a net change of +11 holders.
  • The largest InspireMD buyer in Q1 2021 was Renaissance Technologies, an estimated $1.5M added.
  • The largest InspireMD seller in Q1 2021 was Sabby Management, an estimated $60K sold.

Based on aggregated 13F filings for Q1 2021.